Nicholas Conrad Smith insider trades: Alto Neuroscience (ANRO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicholas reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ANRO | ↓ Sell | 134,886 | $26.45 | $3.6M | Direct | Oct 1, 2026 (1d) |
| Mar 28, 2024 | ANRO | ↑ Buy | 6,150 | $16.36 | $101K | Direct | Apr 1, 2024 (4d) |
| Feb 6, 2024 | ANRO | ↑ Buy | 1,563 | $16.00 | $25K | Direct | Feb 7, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Nicholas Conrad Smith's insider trades
Nicholas Conrad Smith is President and CFO at Alto Neuroscience (ANRO). Since Feb 6, 2024, Nicholas has reported 2 open-market purchases worth $126K and 1 sale worth $3.6M on SEC Form 4. In the last 12 months: 1 sale ($3.6M).
Their filings also include grants and awards (3 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.